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RESEARCH ARTICLE
Anti-inflammatory and antinociceptive effect of Pachygone ovata leaves
Shirin Marahel and Sharanaiah Umesha
Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore, Karnataka, India
ABSTRACT
Context: Pachygone ovata (Poir.) Miers ex Hook. F. et Thoms (Menispermaceae) is a rich source of bioactive
bisbenzylisoquinoline and aporphine alkaloids.
Objective: This study investigates the in vitro and in vivo anti-inflammatory and antinociceptive potential
of Pachygone ovata leaves.
Materials and methods: Lipoxygenase (LOX) assay for anti-inflammatory activity was conducted using
MeOH, EA, H and Aq extracts; followed by alkaloid isolation. The anti-inflammatory potential was deter-
mined using carrageenan-induced paw oedema and formalin tests for evaluation of Pachygone ovata anal-
gesic effect. Different doses (100, 300 and 400lg/kg) were administered orally to Wistar rats for a period
of one week, once daily.
Results: MeOH and EA extract efficiently inhibited LOX (IC50 1.43 and 2.15lg/mL, respectively). MeOH
extract had better inhibiting capacity (57%) than indomethacin (51%) in carrageenan induced rats. MeOH
extract (300 lg/kg) significantly reduced the increased levels of nitric oxide (8 ±0.57 M), total leukocyte
count (4.5 ± 0.05 cells 103/cells) and C-reactive protein (55± 0.45mg/mL). There was a decrease in various
serum biochemical markers (ALT, AST). Histopathological studies revealed reduction in oedema and
decreased cellular infiltration on supplementation with MeOH extract. Furthermore, MeOH extract (300lg/kg)
and alkaloid fraction (400 lg/kg) effected both phases (neurogenic and inflammatory) of formalin injected
models.
Discussion and conclusion: Inflammatory mediators play a key role in inflammation; therefore, keeping it
in control is of utmost importance. The usefulness of Pachygone ovata leaves on pain and inflammation
has been described, probably due to its effect on inflammatory mediators and high alkaloid content.
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Introduction
Inflammation is the body’s mechanism of defending itself against
the cellular injury and challenges faced by the invader, which may
result in release of inflammatory mediators to cause restoration of
tissue function and structure. However, continuation and persist-
ence of the inflammation can be harmful and contribute to gen-
esis of various diseases; characterized by oedema formation,
leukocyte infiltration and granuloma formation (Mitchell &
Cotron 2000). Keeping in mind the adverse effects of oxidative
stress and inflammatory processes in the development of many
chronic diseases, it is worthwhile to look into the unexplored
realm of medicinal plants with properties that can neutralize these
repugnant effects.
According to Indian folk medicine, species of the
Menispermaceae family have been used against diabetes, oedema,
pain, rheumatoid arthritis, bone fracture, nephritis, pyrexia and
hypertension (Kirtikar & Basu 1975; Pongboonrod 1979; Caius
1986; Chopra et al. 1996). Most species of the Menispermaceae
family have been found to be rich in alkaloids, of which curare, an
isoquinoline or indole alkaloid isolated from Chondrendron tomen-
tosum Ruiz and Rulz has been established as an arrow poison by
indigenous people of Guyana. Further investigation advanced its
use to an anaesthetic during surgeries (Krishnaswamy &
Sundaresan 2013). Chasmanthera dependens Hoscht. has shown to
have anti-inflammatory and analgesic effects on laboratory animals
(Onabanjo et al. 1991; Morebise et al. 2001); its constituents
include berberine-type alkaloids (Iwu et al. 1999), quaternary alka-
loids and non-phenolic alkaloids (Ohiri et al. 1982). Cissamplos
pareira L. was used as a traditional folk medicine for its antiseptic
properties against inflammation and for wound healing, which was
reported to have high alkaloid content by Neuwinger (1994).
Tinospora crispa (L.) Miers ex Hook. F. et Thoms. is claimed to be
effective against rheumatism and arthritis (Quisumbing 1978).
Benzylisoquinoline, protoberberines and aporphines constitute
about 40% of the total alkaloids isolated from this family.
Bisbenzylisoquinoline alkaloids have been reported to inhibit
inflammatory mediators and play an important role in control of
inflammation (Teh et al. 1990; Akiba et al. 1992).
Pachygone ovata (Poir.) Miers ex Hook. F. et Thoms. has been
an unexplored and trivialized plant from the Menispermaceae
family despite containing a number of interesting alkaloids such
as coclaurine, reticuline, trilobine, pachyovatamine (benzylisoqui-
noline alkaloids) magnoflurine (aporphine alkaloid), norjuziphine
(benzyltetrahyroisoquinoline alkaloid), liriodenine, pachygonine
(erythrina alkaloid), etc. (Dasgupta et al. 1979; Bhat et al. 1980;
El-Kawi et al. 1984; Uvais et al. 1985). Traditionally only its use
as a fish poison and vermicide has been highlighted (Hooker
1961; Kirtikar & Basu 1975). Since there is no scientific validation
for any pharmacological attributes to Pachygone ovata, this
research investigates the crude extract and alkaloid fraction of
P. ovata for anti-inflammatory potential both in vitro and in vivo.
In vitro assay was based on the inhibition of the lipoxygenase
enzyme (15-LOX) isolated from soybean and the in vivo analysis
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was conducted using models of inflammatory pain (i.e., formalin-
induced licking) and acute inflammation (i.e., carrageenan-
induced oedema).
Materials and methods
Animals
The present study was conducted in accordance with internation-
ally accepted principles for laboratory animal use and care. All
experimental procedures were approved by the Institutional
Animal Ethics Committee (IAEC) and received approval number
UOM/IAEC/18/2013, dated 28/9/2013. The animals were pro-
cured from the Animal House Center, Department of Zoology,
University of Mysore, India, and were maintained in colony cages
at 25 ± 3 C, with a relative humidity of 45–50%, under 12/12 h
light and dark cycles. The experiments were conducted on male
Wistar rats weighing 150–200 g. The animals were fed with
laboratory chow and water ad libitum. The animals were allowed
to acclimatize to the experimental room for 24 h before the
experiments.
Reagents
All the chemicals and solvents were of analytical grade and pro-
cured from various sources. k-Carrageenan from Sigma-Aldrich
(Switzerland); indomethacin, vanadium chloride, Griess reagent,
LOX enzyme, linoleic acid, ammonium hydroxide, disodium sul-
phide and other chemicals were purchased from Sigma-Aldrich
(India), while Thiourea was from Sisco Research Laboratories
(India). Kits were procured from Merck Millipore – USA and
Cayman Bio Trend – Germany.
Plant collection and extraction
The aerial parts of Pachygone ovata were collected from
Chammundi hills, Mysore, Karnataka, India in August 2012. Dr.
G.R. Shivamurthi (former Professor, Department of Botany,
University of Mysore, Mysore, India) botanically identified and
authenticated the plant. An authenticated voucher specimen of
the plant (UMDB/SU/Po-5) was deposited in the herbarium of
Department of Studies in Biotechnology, University of Mysore,
Manasagangotri, Mysore, India for future reference. The plant
leaves were washed under running tap water and allowed to dry
at room temperature. Further, 700 g of the dried leaves of
Pachygone ovata was taken and crushed into a fine powder and
extracted by exhaustive percolation following the method of
Sultana et al. (2009) with slight modification using hexane (H),
ethyl acetate (EA), methanol (MeOH) and water (Aq). The sol-
vents were transferred to flash evaporator for complete evapor-
ation resulting in dried hexane, ethyl acetate, methanol and
aqueous extracts (Sultana et al. 2009).
In vitro anti-inflammatory potential
Lipoxygenase inhibition assay
The LOX assay was evaluated according to the method of
Malterud and Rydland (2000), with slight modification. Serial
dilutions of the extracts (MeOH, EA, H and Aq) were prepared
in a 96-well microtitre plate over a range of 0.1–50lg/mL. Briefly,
495 lL of phosphate borate (0.1 M, pH 9) was added to 5 lL of
extracts and 500 lL of linoleic acid solution (0.15mM in water).
The reaction was initiated by adding 495 lL of enzyme solution
(0.28U/mL of phosphate borate). Quercetin was used as a stand-
ard. Temporal pattern and enzyme activity was measured at
234 nm for 2min with appropriate controls. Lipoxygenase inhib-
ition was calculated from the following formula:
Inhibition (%)¼ [(A-S)/A] 100; where, A¼ absorbance of
assay without extract and S¼ absorbance of assay with extract.
Partial alkaloid extraction
The methanol extract was further resuspended in hydrochloric
acid (2N) and washed with ethyl ether three times. The aqueous
fraction was collected, alkalized using ammonium hydroxide and
washed three times with ethyl ether. The ethereal fraction was
allowed to dry, resulting in a purified alkaloid fraction (AF) (Silva
et al. 2013).
The residue was dissolved in methanol, subjected to TLC using
chloroform:methanol:acetic acid:water (6.25:2.77:0.830:0.138). The
plates were observed under UV light (254 and 365 nm). Blue,
blue-green and yellow fluorescent stains at 365 nm and pro-
nounced quenching (blue-violet stain) at 254 nm are indicative of
alkaloids (Wagner et al. 2006).
Estimation of alkaloids precipitable with Dragendorff’s reagent
Spectrophotometric method was used to evaluate the amount of
alkaloids precipitable with Dragendorff ’s reagent (Sreevidya &
Mehrotra 2003). Based on this method the yellow bismuth
complex that is formed in nitric acid medium with thiourea is
in direct correlation with the amount of alkaloid present in the
plant. Approximately 2 g crude extract was dissolved in ethanol
and hydrochloric acid (1%) to give a final concentration of
60mg/mL with a pH of 2–2.5. An aliquot of the extract solu-
tion (5mL) was added to 2mL of Dragendorff’s reagent, the
precipitate formed was centrifuged for 30min at 2400 rpm. The
residue was then washed with ethanol and treated with 2mL of
disodium sulphide solution. A brownish-black precipitate was
formed which was again centrifuged and then dissolved in con-
centrated nitric acid (2mL). This solution was made up to
10mL using a standard flask with distilled water. This solution
(1mL) was taken and 5mL thiourea solution (3%) was added
and absorbance was measured at 435 nm against a blank con-
taining nitric acid and thiourea. The amount of alkaloids pre-
sent was calculated by the absorbance of the sample and the
calibration curve. The quantification procedure indicated the
percentage of alkaloids in the Pachygone ovata leaves to
be 1.26%.
Acute toxicity
Acute toxicity was conducted by estimating the LD50 which is the
lethal dose that can kill 50% of the animal population in 24 h
post treatment with the plant extract. Different concentrations
(500, 1000, 1500 and 2000mg/kg) were administered orally. The
animals were then observed for 24 h for any behavioural changes
or even death (Upmanyu et al. 2011). At the end of the study the
animals were counted for the calculation of LD50 according to
the method of Karber (1931). Using the equation: LD50¼
LD100R(a b)/n
n¼ total number of animal in a group.
a¼ the difference between two successive doses of adminis-
tered extract/substance.
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b¼ the average number of dead animals in two successive
doses.
LD100¼ Lethal dose causing the 100% death of all test animals.
In vivo anti-inflammatory potential
Carrageenan-induced paw oedema
The anti-inflammatory effect was evaluated by the carrageenan-
induced paw oedema method in rats (Winter et al. 1962) with
modification (Ferreira et al. 2013). Extract samples were diluted
using sterile distilled water. Methanol extract (MeOH) of
Pachygone ovata (100 and 300mg/kg), AF (400mg/kg) and indo-
methacin (10mg/kg) were given to the animals by oral route once
daily for one week before inducing paw oedema. Animals were
divided into six groups each containing six animals. Indomethacin
was used as a positive control, the other three groups were used
for treatment with the extracts, one group was only treated with
carrageenan and the control was only fed with water. The group
treated with carrageenan was considered as the maximum of
inflammation and the other groups were compared to this group.
The paw edema was induced by injecting carrageenan (0.1mL,
0.1%, in 0.9% saline w/v) into the sub plantar tissue of the right
hind paw, after half an hour of the treatment with the extract and
standard drug. By measuring the water displacement by plethys-
mometer the paw thickness was measured before carrageenan
injection and every hour after the oedema induction for 4 h (1, 2,
3 and 4 h). Paw swelling was expressed as thickness variation (D)
(Hoffmeister et al. 2011).
Blood sample collection
Animals were anesthetized and further sacrificed following the
ethical guidelines and blood samples were collected by heart
puncture. For leukocyte count blood was collected in EDTA blood
sample tubes and for analysis of C-reactive protein (CRP), NO,
AST and ALT the serum was separated from the blood samples
collected in different tubes.
Histological analysis of paw tissue
Entire paw sections (5mm) were removed from all groups of ani-
mals and immersed in 10% formalin at room temperature. After
decalcification, each sample was embedded in paraffin wax, there-
after, using microtome, sections of 5 lm were cut and mounted
on a glass slide and dried over night at 37 C. Sections were
cleared, hydrated and stained with hematoxylin and eosin for
histological examination and observed under Axio Imager 2
(Ziess, Oberkochen, Germany) microscope with 10 objective
followed by photographs taken of the structural abnormalities
using AxioCam MRc 5. Analyses of the figures were carried out
by AdobeV
R
PhotoshopV
R
(Adobe Systems). To avoid bias judgment
the slides were labelled with numbers.
Measurement of blood cell count and CRP
The total and differential cell counts were determined with a haemo-
cytometer. Plasma CRP level was measured using C-reactive protein
ELISA Kit, Rat (Merck Millipore, Temecula, CA).
Quantification of NO concentrations in serum
To determine nitric oxide (NO) Griess method (Grisham et al.
1996) adapted by Vysakh et al. (2014) was used. In the presence
of H2O, NO gets converted rapidly to nitrite (NO2
) and nitrate
(NO3
). Serum samples (0.1mL) were transferred to cuvettes and
vanadium chloride 0.05 M (0.15mL) in HCl 1.0 M (0.05mL) was
added which cause reduction of nitrate to nitrite. Immediately,
Griess reagent [1% sulphanilamide and 1% N-[naphthyl] ethyl-
enediamine dihydrochloride: 1:1] was added and after 45min
incubation at 37 C absorbance was read at 550 nm in an ELISA
plate reader (Molecular Devices, Sunnyvale, CA). Nitrite concen-
trations were estimated from a sodium nitrite (NaNO2) standard
curve.
Biochemical markers of toxicity
The serum collected from the carrageenan inflamed rats was sub-
jected to analysis for detecting the different levels of alanine ami-
notransferase (ALT) and aspartate aminotransferase (AST); using
standard procedures that are provided with the commercially
available kits (Alanine Transaminase and aspartate aminotransfer-
ase Colorimetric Activity Assay Kit-Cayman chemicals, Ann
Arbor, MI). ALT and AST were spectrophotometrically measured.
Formalin test
The antinociceptive effect was evaluated by the method previously
described by Meunier et al. (1998) with slight modifications, by
administering 50 lL of 5% formalin subcutaneously into the left
hind paw of the rat. The number of licking (times) was recorded
from 0 to 5min (phase 1, neurogenic) and from 20 to 40min
(phase 2, inflammatory) after the formalin injection. The control
group was treated with normal saline; other groups were treated
with the extract (100 and 300mg/kg) and AF (400mg/kg) by oral
route administration 30min before formalin injection. Aspirin
was used as a positive control. The antinociceptive effect was eval-
uated based on the reduction in licking/biting mean time in com-
parison to the control group.
Statistical analysis
In vitro results are obtained by three independent experiments
performed in triplicate and presented as mean ± SD. In vivo
experiments are presented as mean ± S.E.M. and each group con-
tained six rats. Statistical analysis was conducted using SPSS sta-
tistics software. The statistical significance between groups was
compared using one-way analysis of variance (ANOVA) followed
by Tukey test when appropriate. p Values lower than 0.05
(p< 0.05) were considered to be indicative of significance.
Results
Extraction yield
The average yield obtained by MeOH was (55 to 60 g) followed
by EA (27 to 33.5 g), Aq (18.5 to 20.5 g) and H (10.8 to 17.4 g).
In vitro anti-inflammatory activity
LOX assay
The anti-inflammatory potential was evaluated using the inhib-
ition percentage of lipoxygenase enzyme in correlation to their
IC50 values. The MeOH and EA fraction efficiently inhibited the
lipoxygenase by 70.33 ± 0.88% and 66 ± 1.15%, respectively; while
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H extract showed least inhibiting capacity (17.9 ± 1.1% inhibition).
Aq extract did not exhibit any inhibition and therefore is not
included in the table. The IC50 values are listed Table 1 with
MeOH extract having least value with an IC50 of 1.43±1.19 (lg/mL)
followed by EA (2.15±0.9lg/mL) and H (14.4± 1.0lg/mL).
Quercetin exhibited an IC50 of (1.02 ± 0.9 lg/mL).
Partial alkaloid extraction
The different types of alkaloids present in the extract have been
listed in Table 2. At a wavelength of 254 nm four and at 365 nm
seven different types of alkaloids were separated based on their Rf
values.
Acute toxicity
There were no behavioural changes or toxic symptoms observed
24 h post administration, implying their safety margin up to
1500mg/kg. At 2000mg/kg there was 100% death observed, there-
fore the LD50 was recorded to be 1500mg/kg body weight.
In vivo anti-inflammatory potential
Carrageenan-induced paw oedema
Pretreatment with different doses of extract and AF considerably
reduced the paw volume (lL) in the 3 and 4 h and almost neu-
tralized the swelling as compared to the control group by the 4 h.
Percentage of paw swelling from 1 to 4 h has been tabulated
(Table 3). Figure 1 shows the maximum effect at the 4th h by
MeOH extract (300mg/kg) on the paw oedema reduction.
Histopathological analysis of paw tissue
The histopathological results from oedema paws are shown in
Figure 2. The stratum corneum has remained intact and no cellu-
lar infiltration or oedema was observed in control groups (Figure
2(a)). In contrast, the carrageenan injected models showed
absence of stratum corneum, excess polymorphonuclear (PMN)
infiltration, septal panniculitis and oedema. The collagen fibres
were degenerated and foreign-body granuloma (macrophages,
lymphocytes, and neutrophils) accumulation was observed (Figure
2(b)). Administration with MeOH extract (300mg/kg) and AF
(400mg/kg) significantly reduced the PMN infiltration and
oedema. The stratum corneum was intact in models treated with
MeOH extract (300mg/kg) (Figure 2(e,d)). However, only slight
improvements were observed in PMN infiltration and oedema
using MeOH extract at 100mg/kg body weights (Figure 2(c)). The
reference drug indomethacin exhibited similar effects as that of
MeOH extract at 300mg/kg body weights (Figure 2(f)).
Measurement of CRP and leukocyte count
The concentration of CRP (Table 4) was increased significantly
(70 ± 0.42 versus 48 ± 0.56mg/mL) in carrageenan-induced rats
when compared to the control group (normal rats). However,
treatment with MeOH extract (300mg/kg) significantly reduced
CRP concentration (55 ± 0.45 versus 70 ± 0.42mg/mL, p< 0.05)
(Table 4).
Similarly, there was a notable increase in the leukocyte count
(7.0 ± 0.07 versus 4.0 ± 0.05 cells 103) in carrageenan induced
rats compared to normal rats. However, treatment with MeOH
extract (300mg/kg) significantly reduced the leukocyte count
(4.5 ± 0.05 versus 7.0 ± 0.07 cells 103, p< 0.05) (Table 4).
Determination of NO concentrations in serum
It is clearly evident from the present study that an increase in
P. ovata concentration caused a decrease in NO concentration.
MeOH extract at 300mg/kg reduced the NO concentration back
to normal. Similarly AF reduced the NO levels to more than 50%
of the nitrite accumulation (Table 4). Increasing the concentration
did not have any significant effect on the NO concentration
further.
Biochemical markers of toxicity
Alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) are indicators of liver, muscle and kidney injury. In
carrageenan-induced rats the ALT and AST increased to a small
Table 1. Results of lipoxygenase inhibitory effect of crude
Pachygone ovata extracts.
Samples % of Inhibition (lg/ml)* IC50 (lg/ml)
MeOH 70.33 ± 0.88b 1.43 ± 1.19
EA 66± 1.15a 2.15 ± 0.9
H 17.9 ± 1.1b 14.4 ± 1.0
Quercetin 92 ± 1.07 1.02 ± 0.9
*Each value is represented as mean ± SEM (n¼ 3). He:
Hexane extract, EA: Ethyl acetate extract, MeOH: Methanol
extract. Values differ significantly at ap< 0.01, bp< 0.05
when compared with quercetin (control).
Table 2. Substances characterized by TLC.
Mobile phase Wavelength Rf
Chl: MeOH: AcOh: H2O
6.25: 2.77: 0.830: 0.138
254 nm: blue-violet stain 0.47
0.40
0.20
0.11
365 nm: yellow fluorescence 0.56
0.44
0.26
Blue fluorescence 0.37
0.19
0.16
Blue-Green fluorescence 0.12
Chl: Chloroform; MeOH: Methanol; AcOh: Acetic acid and H2O:
Water.
Table 3. Percentage paw swelling in carrageenan inflamed rats at different time intervals.
Samples 1 h (%) 2 h (%) 3 h (%) 4 h (%)
Carrageenan 73.1 ± 133.3 78 ± 72.6 72.6 ± 57.7 69 ± 28.8
Indomethacin 51.4 ± 104a 43 ± 66.6b 27 ± 76.3a 10.8 ± 5.7a
MeOH extract (100mg/kg) 56.4 ± 93.3b 49 ± 88.1b 36 ± 66.6c 20.5 ± 20.8a
MeOH extract (300mg/kg) 52.7 ± 75b 37.5 ± 50b 14.3 ± 90c #
AF (400mg/kg) 54.7 ± 120.1b 46 ± 92.7b 32 ± 83.3c 12.5 ± 16b
#Same size as control group. All samples are treated with carrageenan except positive control. Values differ sig-
nificantly at ap< 0.01, bp< 0.03, cp< 0.05 in each sample compared to carrageenan control at each specified
hour.
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extent of 117 ± 8.5 and 312 ± 15.6U/L, respectively and were
reverted back to normal using 300mg/kg MeOH extract and AF.
MeOH extract (100mg/kg) did not have a significant effect on
reduction of the ALT (112.6 ± 13) and AST levels (301 ± 12)
(Table 4).
Formalin test
Two spontaneous behaviours (flinching/shaking and licking/bit-
ing) indicative of pain were recorded immediately after the sub-
cutaneous injection of formalin in the right hind paw. In the
control rats (formalin-treated rats), a subcutaneous injection of
formalin resulted in biphasic flinching and licking of the injected
paw. Oral administration of MeOH extract (100 and 300mg/kg)
30min prior to formalin injection significantly decreased the sum
of flinching in MeOH extract (300mg/kg), not in MeOH extract
(100mg/kg) in phase 1 as compared with the control group. In
phase 2 both 100 and 300mg/kg inhibited the licking/biting up to
20.7% and 42.3%, respectively, at 30min. Similarly, AF showed
potential reduction in the phase 1 flinching, however, in phase 2
its potency to reduce the licking/biting was almost similar to
MeOH extract (100mg/kg). Administration of aspirin did not
have an effect on the flinching (phase 1), while it significantly
reduced the licking/biting in the second phase. The inhibitory
effect of MeOH extract at 300mg/kg (87.7%) was slightly better
compared with aspirin (83.3%) (Figure 3).
Discussion
The rapidly burgeoning research to find an anti-inflammatory
drug with minimal side effects, better potential and devoid of
dependance liability has inspired this research work.
Acute and chronic inflammations are complex processes that
are inducible by a variety of means and involve many activated
immune cells. In the present study LOX assay is used as an
in vitro indicator of anti-inflammatory potential of P. ovata and
carrageenan induced oedema is used to evaluate its effects in vivo.
Controlling the LOX enzyme is of significance as it initiates
the formation of pro-inflammatory leukotrienes (LTs) from
arachidonic acid. LTs have different biological effects amongst
which leukocyte aggregation, smooth muscle contraction and vas-
cular permeability are some of the few to name; that these bio-
logical effects have been seen in inflammatory disorders such as
asthma, rheumatoid arthritis, inflammatory bowel disease and
psoriasis (Vickers 1995). Additionally, 15-lipoxygenase is also of
interest due to its possible role in the development of atheroscler-
osis (Henriques et al. 1987), therefore, keeping it in control is of
utmost importance especially in the inflammation process. In the
present work the inhibitory capacity amongst different extracts
varied from 17.9 to 70.33, methanol extract having the highest
inhibitory effect on LOX enzyme as expected and hexane extract
having the lowest inhibitory effect. Since the in vitro studies has
provided evidence of the methanol extract showing better activity,
a semi fractionation was carried out to separate the alkaloids to
give us a better insight of the effect of alkaloid components on
the inflammation induced by carrageenan in rats. Quercetin is
mainly used as a standard as it is a known flavonoid that is dis-
tributed widely in nature and its anti-inflammatory effects have
been well established in various reports (Guardia et al. 2001;
Hamalainen et al. 2007).
Carrageenan-induced inflammation is a well-established
method for anti-inflammatory evaluation of drugs and is also
known to cause biphasic acute inflammation (Henriques et al.
1987). The initial phase (0–1 h) has been attributed to the release
of histamine, 5-hydroxytryptamine (serotonin), bradykinin, cyto-
kines, as well as TNF-a and ILs (Di Rosa & Willoughby 1971; De
ciga-Campos et al. 2007). While, the second phase (1-6 h) is accel-
erated by over production of prostaglandins and cyclo-oxygenase
(COX-2) with local neutrophil infiltration and activation contribu-
ting alongside (Di Rosa & Willoughby 1971; Vinegar et al. 1971;
Seibert et al. 1994; De ciga-Campos et al. 2007).
Amongst other important mediators produced is NO which is
a potent vasodilator and increases vascular permeability which
causes oedema through changes in the blood flow (Moncada et al.
1991). Reports suggest NO exerts multiple cytotoxic effects during
inflammation including increase in prostaglandin (PG) production
and formation of peroxynitrite (a potent oxidizing molecule)
which is capable of evoking lipid peroxidation and thereafter
Figure 1. Carrageenan-induced rat paw oedema. Effect of MeOH extract (100 and 300mg/kg), AF (400mg/kg) and indomethacin on rat paw oedema induced by carra-
geenan. Results represent the mean±S.E.M. of percentage of variation (n¼ 6). Values differ significantly at *p< 0.01, **p< 0.03, #p< 0.05 in each sample compared to
carrageenan control at each specified hour. MeOH: methanol extract and AF: alkaloid fraction.
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cellular damage, stimulating the recruitment of leukocytes, ampli-
fying the inflammatory response (Beckman et al. 1990; Bhatia
2010). Another important inflammatory marker are the CRP,
these were described as ‘acute-phase reactants’ by Avery and
McCarty due to their increase in serum in patients with inflam-
matory stimuli. These CRP molecules bind to the pathogens and
initiate their destruction via the complement system (McCarty
1947; Chandrashekara 2014).
Our results suggest that MeOH extract and alkaloid fraction
may owe its oedema inhibitory effect, at least in part, to the
inhibition of some of the several mediators released during
inflammation. Administration of carrageenan induced rats with
Figure 2. Histopathologic analysis of the effects of MeOH extract (100 and 300mg/kg) and alkaloid fraction (AF) on cell infiltration in carrageenan injected paws.
(a) Control group (b) Carrageenan injected group (c) MeOH extract (100mg/kg) treated group (d) AF (400mg/kg) treated group (e) MeOH extract (300mg/kg) treated
group (f) Indomethacin treated group. Cross sections of paws shows intact stratum corneum (ISC) in control, indomethacin and MeOH extract (300mg/kg) treated groups,
damaged stratum corneum (DSC) in carrageenan injected and AF-treated groups, hyper stratum corneum in groups treated with MeOH extract (100mg/kg). In control
group epidermal (E) and sub epidermal (SE) layer remain unchanged. In carrageenan injected group there is an influx of inflammatory cells infiltration (ICI), sub epidermal
oedema (SEO), macrophages and septal paniculitis (SP). In MeOH extract (100mg/kg) treated rats hyper stratum corneum (HSC) and damage of subcutaneous (DSC) layer
was observed. In AF and MeOH extract (300mg/kg) treated groups mild infiltration (MI), mild sub-epidermal oedema (MSEO) and restored subcutaneous (RSC) layer was
observed. Damaged connective tissue (DCT) was seen in some places in indomethacin-treated paw tissues.
Table 4. Inhibitory effect of Pachygone ovata on the concentration of plasma CRP, leukocyte count, NO, ALT and AST activity.
Groups CRP (mg/ml) leukocytes (cells 103/cells) NO (M) ALT (U/L) AST (U/L)
Control 48 ± 0.56 4.0 ± 0.05 2.2 ± 0.14 93.4 ± 18 275 ± 8.2
Carrageenan 70 ± 0.42 7.0 ± 0.07 26.6 ± 0.8 117 ± 8.5 312 ± 15.6
MeOH (100mg/kg) 63 ± 0.78a,b 5.9 ± 0.02a,b 19.6 ± 0.3a,b 112.6 ± 13a,b 301 ± 12a,b
MeOH (300mg/kg) 55 ± 0.45a,b 4.5 ± 0.05a,b 8 ± 0.57a,b 98 ± 20a,b 290 ± 17.2a,b
AF (400mg/kg) 58 ± 0.72a,b 4.8 ± 0.05a,b 14.3 ± 1.2a,b 98.7 ± 10a,b 293 ± 10.3a,b
Indomethacin 53 ± 0.34a,b 4.1 ± 0.02a.b 11.6 ± 0.8a,b 95 ± 4.3a,b 285 ± 7.3a,b
Values are expressed as average of 6 samples ± S.E.M in each group. MeOH: Methanol extract and AF: Alkaloid fraction.
aValues differ statistically with control at p< 0.05.
bStatistical difference with carrageenan induced rats at p< 0.05.
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different concentrations of extract promoted a significant reduc-
tion in the oedema from the 1st h dose dependently. This suggests
that the anti-edematogenic effect is related to the modulation of
various enzymes and has various anti-inflammatory mechanisms
of action mainly focusing on inhibiting the production of PGs
and NO. To complement this, NO levels that had increased sig-
nificantly at the 4 h after carrageenan induction was notably
reduced with using higher concentration of the extract. This con-
firms the effect of methanol extract on inhibiting the inflamma-
tion with respect to monocyte and neutrophil migration at the
inflammatory site. Additionally, CRP and leukocyte count were
increased with carrageenan administration pointing out the
inflammation since they act as acute phase reactants, but there
was a notable decrease observed upon administration with metha-
nol extract and alkaloid fraction. This was comparable to that of
indomethacin treated rats, which supports the inhibition of paw
swelling in P. ovata treated rats.
Furthermore, chronic inflammation causes the disruption of
the lysosomal membrane leading to leakage of lysosomal enzymes
(ALT and AST) into the blood stream (Tanaka & Lizuka 1968).
The slight increase in these biochemical markers were decreased
by the methanol extract and alkaloid fraction, although, both were
not as effective as the nonsteroidal anti-inflammatory drug used
(indomethacin). But overall, the results from carrageenan-induced
oedema demonstrated that methanol extract and alkaloid fraction
were able to reduce the oedema suggesting their significance in
acute inflammation.
In the model of formalin-induced pain, a biphasic behavioural
change was observed in the rats such as flinching/shaking and
licking/biting, the first being of neurogenic origin (Hunskar &
Hole 1987) and the second being of inflammatory origin due to
release of inflammatory mediators (PGs, NO, histamine)
(Sulaiman et al. 2010). Our results showed that methanol extract
at 100mg/kg had no effect on the first phase while its nociceptive
effect was apparent in the second phase, but at 300mg/kg there
was an apparent inhibition of both phases (neurogenic and
inflammatory). The alkaloid fraction followed a similar pattern; it
notably inhibited the phase 1 and had a significant inhibitory
effect on phase 2 as well. Although in the case of aspirin (positive
control) only in phase 2 the licking/biting was notably reduced,
this is in corroboration with previous studies that non-steroidal
anti-inflammatory drugs (NSAID) are effective in the second
phase of formalin test due to the inhibitory activity on PG synthe-
sis in the modulation of pain (Hunskar & Hole 1987; Tsolen et al.
1992). It is well known that drugs such as morphine act primarily
on the central nervous system and can therefore inhibit both
phases equally (Shibata et al. 1989), from this we can understand
that methanol extract of P. ovata at a concentration of 300mg/kg
body weights might have central antinociceptive effect and can
exert its inhibitory effect peripherally as well as on the central
nervous system. Since the alkaloid fraction followed a similar pat-
tern, it can be hypothesized that this property of the methanol
extract may be partially related to the alkaloid content present in
it.
Therefore, from our studies it can be concluded that P. ovata
can be used as an alternative NSAIDs with further investigation
on individual effect of the components. This is the first report of
P. ovata being studied for its pharmacological activity. It is evi-
dent from our study that pretreatment with methanol extract and
alkaloid fraction can reduce swelling during inflammation owing
this property to its inhibitory effect on NO and in turn on PGs,
therefore, reducing cell infiltration and causing a decrease in
oedema. The nociceptive effect of P. ovata also has been justified
in the formalin induced pain model. The mechanism of anti-
inflammatory and antinociceptive activities from P. ovata may be
explained by the presence of alkaloids such as coclaurine, reticu-
line, norjuzophine, trilobine (Dasgupta et al. 1979; Bhat et al.
1980) and different components of the plant acting
Figure 3. Effect of oral administration of MeOH extract (100 and 300mg/kg), AF (400mg/kg) and aspirin on the time course of the flinches/licking observed after the for-
malin injection. The number of flinches and licking/min is plotted versus time after formalin injection. Each line represents the group mean± S.E.M. (n¼ 6). Values differ
statistically with control at *p< 0.05, **p< 0.1 in each sample.
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simultaneously and amplifying the individual effect in a compli-
mentary manner. In our study the alkaloid fraction alone was not
as significant in terms of anti-inflammatory as compared with the
methanol extract; this could be due to the complex mixture of
phytochemicals from the plant acting through a combination of
additive and/or synergic interactions also indicating that the
pharmacological effect of P. ovata is dependent on other phyto-
chemicals apart from the alkaloids alone in it. Further line of
studies is being undertaken to determine the various components
and to analyze their effect individually on various in vitro and
in vivo studies. To summarize, this work demonstrates that frac-
tions from the leaves of P. ovata exhibit anti-inflammatory activ-
ity when given by oral route and even at higher concentrations
did not possess any toxic effect on the rodents.
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